The proposal led by Javier Crespo from IDIVAL and Valdecilla will demonstrate a coordinated screening model for metabolic liver disease in patients with type 2 diabetes, scalable to other healthcare systems The proposal El Modelo Cantabria (The Cantabria Model), submitted by researchers from the Valdecilla Research Institute (IDIVAL) and the Marqués de Valdecilla University Hospital […]
The Marqués de Valdecilla Research Institute (IDIVAL) welcomed Rodrigo Ruiz and Denis Opresnik, representatives of the sustainability work package of the European Joint Action JACARDI and members of the National Institute of Public Health Slovenia. The visit provided an opportunity to exchange experiences and discuss strategies to ensure that the achievements promoted by JACARDI in […]
The Neurology Department of the Marqués de Valdecilla University Hospital (HUMV) has published a study offering new insights to improve preventive migraine treatment with monoclonal antibodies targeting CGRP (Calcitonin Gene-Related Peptide). The research was conducted by neurologists from the Headache Unit, led by Marcos Polanco, first author of the study, together with biotechnologist Gabriel Gárate, […]
The SAM Project (an acronym for Health, Social, Assets and Map), led by the Marqués de Valdecilla Research Institute (IDIVAL) with principal investigator Olga De Cos from the Health Economics group, continues to make progress in developing its social prescribing model with the completion of new fieldwork sessions in Bayonne and the simultaneous advancement of […]
The use of new conditioning regimens in allogeneic hematopoietic stem cell transplantation could improve treatment tolerance in patients with myeloid neoplasms. This is suggested by the study “Real-world experience of treosulfan in allogeneic stem cell transplantation in adult patients with myeloid malignancies”, which examines real-world clinical experience with this drug. The study focuses on the […]
The initial meeting (Kick-off Meeting) of the European project “AI that Cares for Aging at Home” (Care@Home) has taken place in Kaunas (Lithuania). This international initiative aims to transform the care of older adults through the use of artificial intelligence (AI). The project includes the participation of the Valdecilla Health Research Institute (IDIVAL), together with […]
A nationwide multicentre study led by the Marqués de Valdecilla University Hospital demonstrates that lung transplantation is a safe and effective option in patients with advanced pneumoconiosis — mainly silicosis — an irreversible lung disease caused by prolonged inhalation of silica dust. The work has been published in the international scientific journal Respirology and is […]
The Valdecilla Health Research Institute (IDIVAL) has opened the call for the 2026 Competitive Intensification Program, which will remain open until May 15. This program aims to temporarily relieve healthcare professionals with a high research or innovation workload, allowing them to dedicate themselves fully to research projects or the development of new clinical techniques and […]
This morning’s session of the Santander Biomedical Lectures program, organized by the Marqués de Valdecilla Research Institute (IDIVAL), featured a presentation by researcher Adolfo García-Sastre, who delivered a lecture titled “A vaccine platform based on avian paramyxovirus / Una plataforma vacunal basada en paramixovirus de aves.” During his talk, the expert outlined the development of […]
Summary: The joint action Hope4Kids – Comprehensive Oncological Palliative Care for the Children of Europe” aims to strengthen and harmonize pediatric palliative care (PPC) across Europe for all children living with life‑threatening or life‑limiting conditions. Across Europe, many children suffer from severe, complex, or rare chronic illnesses that significantly affect their quality of life and, […]
